Sign in
4/A

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-23-039157

Chief Commercial Officer sold 1,758 shares at an average $17.04 ($29,951)

From the SEC's structured data for this filing

Trades in this filing

Wettig Thane · Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-06-07 Sale : show line 1 in the form −472 $17.04 $8,041 110,338 D
2023-06-07 Sale : show line 2 in the form −1,286 $17.04 $21,910 109,052 D
Open-market sales · 1,758 sh · avg $17.04 · $29,951
Loading xslF345X04/doc4a.xml…